Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
No Evidence for Oversizing Hearts and Donor Size Impact on 1-Year Survival in Heart Failure Patients With Left
Bhavana Siddegowda-Bangalore1, Srikant Devaraj2, Roopa A Rao3
1Division of Cardiovascular Medicine, Orlando Health Heart & Vascular Institute, Orlando, Florida; Miller College of Business, Ball State University, Muncie, Indiana; Advanced Heart Failure and Transplant Fellowship, Indiana University, Indianapolis, Indiana.
Insights
The predicted heart mass (PHM) ratio is a superior metric for heart transplant size matching in left ventricular assist device (LVAD) patients. Undersized donor hearts (PHM ratio <0.83) increase 1-year mortality, while oversized hearts offer no benefit.
Area of Science:
- Cardiology
- Transplantation Surgery
- Medical Metrics
Background:
- Donor-to-recipient size-matching is critical for heart transplant outcomes.
- The predicted heart mass (PHM) ratio is a novel metric outperforming traditional weight ratios.
- Its utility in patients supported by left ventricular assist devices (LVADs) remains unestablished.
Purpose of the Study:
- To evaluate the effectiveness of the PHM ratio for size-matching in heart transplant recipients with LVAD support.
- To compare the PHM ratio against other size-matching metrics (weight, height, BMI, BSA) in this specific population.
Main Methods:
- Retrospective analysis of 11,891 heart transplant recipients with LVAD support from the Scientific Registry of Transplant Recipients (1997-2020).
- Comparison of five size-matching metrics: donor-recipient ratios of weight, height, body mass index, body surface area, and PHM.
- Application of single and multivariable Cox proportional hazards models to assess 1-year mortality.
Main Results:
- The PHM ratio demonstrated superior risk stratification compared to other metrics in LVAD patients.
- Patients receiving undersized donor hearts (PHM ratio <0.83) exhibited a significantly increased hazard ratio for 1-year mortality (1.34, p=0.007).
- No significant difference in mortality was observed between matched (0.83-1.2) and oversized (≥1.2) donor heart groups.
Conclusions:
- The PHM ratio is an optimal metric for donor-recipient size-matching in heart transplant candidates on LVAD support.
- Utilizing undersized donor hearts (PHM ratio <0.83) is associated with higher 1-year mortality.
- Employing oversized donor hearts in LVAD recipients does not confer survival benefits.
Abstract:
The predicted heart mass (PHM) ratio has recently emerged as a better metric for donor-to-recipient size-matching than weight ratios. It is unknown whether this applies to transplant candidates on left ventricular assist device (LVAD) support. Our study examines if PHM ratio is optimal for size-matching specifically in the LVAD patient population. Patients with LVAD who received a heart transplant from January 1997 to December 2020 in the Scientific Registry of Transplant Recipients database were studied. We compared 5 size-matching metrics, including donor-recipient ratios of weight, height, body mass index, body surface area, and PHM. Single and multivariable Cox proportional hazards models for 1-year mortality were calculated. Our sample consisted of 11,891 patients. In our multivariate analysis, we found that patients in the undersized group with PHM ratios <0.83 had a hazard ratio for 1-year mortality of 1.34 (95% confidence interval 1.08 to 1.65, p = 0.007) suggestive of increased mortality with the use of undersized donors. There was no statistical difference in mortality between the matched (PHM ratio 0.83 to 1.2) and oversized group (PHM ratio ≥1.2). In heart transplant recipients on LVAD support, the PHM ratio provides better risk stratification than other metrics. Use of undersized donor hearts with PHM ratio <0.83 confers higher 1-year mortality. Using oversized donor hearts for transplantation in recipients on LVAD support has no benefit.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology
Cardiomyopathy V: Interprofessional Care

